Section 5. Breast: Breast-conserving therapy consisting of wide excision, axillary dissection, and radiotherapy for early-stage breast cancer: The experience of the National Shikoku Cancer Center

Biomedicine and Pharmacotherapy

Volumn 56, Issue SUPPL. 1, 2002, Pages 196-200

  Ohsumi, Shozo ^a,b   Takashima, Shigemitsu ^a   Saeki, Toshiaki ^a   Aogi, Kenjiro ^a  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^b NONE   (Japan)

Author keywords

Breast cancer; Breast conserving therapy; Prognostic factor

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST; BREAST CANCER; CANCER CENTER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISSECTION; EXCISION; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LYMPH NODE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECURRENCE RISK; TUMOR VOLUME; BREAST TUMOR; JAPAN; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SEGMENTAL MASTECTOMY; SENTINEL LYMPH NODE BIOPSY; STATISTICS; SURVIVAL RATE; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 1842865347     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0753-3322(02)00208-1     Document Type: Article

References (12)

1. Anscher M.S., Jones P., Prosnitz L.R., et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg. 218:1993;22-28.
2. Bartelink H., Horiot J- C., Poortmans P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J M. 345:2001;1378-1387.
3. Fisher B., Anderson S., Redmond C.K., et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J M. 333:1995;1456-1461.
4. Fisher B., Dignam J., Bryant J., et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst. 88:1996;1529-1542.
5. Fisher B., Dignam J., Mamounas E.P., et al. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of finding from NSABP-B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol. 14:1996;1982-1992.
6. Fourquet A., Campana F., Zafrani B., et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys. 17:1989;719-725.
7. Haffty B.G., Fischer D., Beinfield M. et al. Prognosis following local recurrence in the conservatively treated breast cancer patients. Int J Radiat Oncol Biol Phys. 21:1991;293-298.
8. Kurtz J.M., Jacquemier J., Amalric R., et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol. 8:1990;591-598.
9. Locker A.P., Ellis I.O., Morgan D.A.L., et al. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg. 76:1989;890-894.
10. Nishimura R., Koyama H., Kasumi F., et al. A case control study on risk factors involved in inflammatory breast recurrence after breast-conserving surgery. Oncology. 55:1998;391-399.
11. Romestaing P., Lehingue Y., Carrie C., et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol. 15:1997;963-968.
12. Veronesi U., Banfi A., Del Vecchio M., et al. Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol. 22:1986;1085-1089.